The Ministry of Science and Technology of India and Bharat Biotech International jointly developed the nasal spray vaccine "iNCOVACC".

(Picture taken from Twitter @CBCJalandhar)

[Instant News/Comprehensive Report] India has recently launched the world's first nasal spray vaccine for Wuhan pneumonia (new coronavirus disease, COVID-19). At present, the vaccine has been officially approved by India and will be used as an additional dose.

According to comprehensive foreign media reports, the Indian Ministry of Science and Technology launched the first Indian-made nasal spray Wuhan pneumonia vaccine "iNCOVACC" jointly developed with Bharat Biotech on the 26th.

The vaccine has been officially approved by India and will be used as an additional dose after two doses of the vaccine for people over the age of 18.

Please read on...

The iNCOVACC vaccine is manufactured with carrier platform technology, so it can deal with new mutant strains by replacing the carrier and achieve large-scale production.

In addition, since the iNCOVACC vaccine does not require syringes, needles, alcohol or bandages, it can also save costs related to storage and medical waste disposal.

Related news please see:

Please click here for the "Wuhan Pneumonia Zone", for more information, you can grasp it first-hand.